Wells Fargo
INDV icon

Wells Fargo’s Indivior Pharmaceuticals INDV Stock Holding History

Wells Fargo’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-354,000
Closed -$12.7M – 7327
2025
Q4 		$12.7M Hold
354,000
– – ﹤0.01% 1847
2025
Q3 		$8.53M Buy
+354,000
New +$7.41M ﹤0.01% 2127

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo's INDV Position: Q2 2026 in Review

Wells Fargo increased its Indivior Pharmaceuticals (INDV) stake by 16% in Q2 2026, buying an estimated $1.7M and bringing the position to 337,635 shares worth $13.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1922.

Wells Fargo first reported a position in INDV in Q2 2023 and has held it in 13 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Wells Fargo held 337,635 shares of Indivior Pharmaceuticals worth $13.9M as of Q2 2026.
  • Wells Fargo bought 46,796 Indivior Pharmaceuticals shares in Q2 2026, an estimated $1.7M.
  • Indivior Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #1922 holding.
  • Wells Fargo first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.